Overall survival (OS) at 7-year (y) follow-up (f/u) in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) who received maintenance olaparib in the SOLO1/GOG-3004 trial Meeting Abstract
| Authors: | DiSilvestro, P.; Banerjee, S.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M. L.; Lisyanskaya, A. S.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; Oza, A. M.; Gonzalez Martin, A. J.; Aghajanian, C.; Bradley, W. H.; Mathews, C.; McNamara, J.; Lowe, E.; Moore, K. N. |
| Abstract Title: | Overall survival (OS) at 7-year (y) follow-up (f/u) in patients (pts) with newly diagnosed advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) who received maintenance olaparib in the SOLO1/GOG-3004 trial |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S779 |
| Language: | English |
| ACCESSION: | WOS:000866211600510 |
| DOI: | 10.1016/j.annonc.2022.07.645 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 517O -- Source: Wos |
